CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
30.01M
HLN
Price
$11.06
Change
-$0.35 (-3.07%)
Updated
Jun 3, 01:22 PM (EDT)
Capitalization
38.4B
58 days until earnings call
Interact to see
Advertisement

CNADF vs HLN

Header iconCNADF vs HLN Comparison
Open Charts CNADF vs HLNBanner chart's image
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization30.01M
Haleon
Price$11.06
Change-$0.35 (-3.07%)
Volume$1.24K
Capitalization38.4B
CNADF vs HLN Comparison Chart
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNADF vs. HLN commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNADF is a Hold and HLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (CNADF: $0.06 vs. HLN: $11.41)
Brand notoriety: CNADF and HLN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CNADF: 15% vs. HLN: 91%
Market capitalization -- CNADF: $30.01M vs. HLN: $38.4B
CNADF [@Pharmaceuticals: Other] is valued at $30.01M. HLN’s [@Pharmaceuticals: Other] market capitalization is $38.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNADF’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 0 green FA rating(s).

  • CNADF’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 0 green, 5 red.
According to our system of comparison, CNADF is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 3 TA indicator(s) are bullish.

  • HLN’s TA Score: 3 bullish, 4 bearish.

Price Growth

CNADF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while HLN (@Pharmaceuticals: Other) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +13.96%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +72.29%.

Reported Earning Dates

HLN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+13.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than CNADF($30M). CNADF YTD gains are higher at: 78.571 vs. HLN (20.970). HLN has higher annual earnings (EBITDA): 2.35B vs. CNADF (4.73M). HLN has more cash in the bank: 994M vs. CNADF (2.79M). CNADF has less debt than HLN: CNADF (6.97M) vs HLN (9.46B). HLN has higher revenues than CNADF: HLN (11.3B) vs CNADF (21.6M).
CNADFHLNCNADF / HLN
Capitalization30M38.4B0%
EBITDA4.73M2.35B0%
Gain YTD78.57120.970375%
P/E RatioN/A29.23-
Revenue21.6M11.3B0%
Total Cash2.79M994M0%
Total Debt6.97M9.46B0%
TECHNICAL ANALYSIS
Technical Analysis
HLN
RSI
ODDS (%)
Bearish Trend 2 days ago
42%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
51%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 21 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
48%
Aroon
ODDS (%)
Bullish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCT42.650.12
+0.28%
Invesco S&P SmallCap Info Tech ETF
PSEP39.840.09
+0.22%
Innovator US Equity Power Buffer ETF-Sep
RAFE36.41-0.01
-0.03%
PIMCO RAFI ESG US ETF
LMBS48.87-0.03
-0.06%
First Trust Low Duration Oppos ETF
MFLX16.49-0.03
-0.18%
First Trust Flexible Muncpl Hgh Inc ETF

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with BJTRF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then BJTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
BJTRF - CNADF
61%
Loosely correlated
N/A
STEK - CNADF
26%
Poorly correlated
-9.34%
PLSH - CNADF
21%
Poorly correlated
N/A
HLN - CNADF
15%
Poorly correlated
+0.53%
PLNH - CNADF
5%
Poorly correlated
N/A
More